To include your compound in the COVID-19 Resource Center, submit it here.

Brentuximab vedotin regulatory update

FDA accepted for review and granted Priority Review to two BLAs from Seattle Genetics for brentuximab vedotin

Read the full 171 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE